Skystar Bio-pharmaceutical Co (SKBI) financial statements (2022 and earlier)

Company profile

Business Address RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE, 00000
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,14211,322
Cash and cash equivalents8,14211,322
Receivables11,00911,090
Inventory, net of allowances, customer advances and progress billings25,90422,962
Inventory25,90422,962
Prepaid expense2,134
Advances on inventory purchases41,06123,439
Deposits current assets491 
Prepaid expense and other current assets2,840
Deferred tax assets364 
Other undisclosed current assets(491) 
Total current assets:88,61571,652
Noncurrent Assets
Property, plant and equipment28,26928,868
Intangible assets, net (including goodwill)5,2375,320
Intangible assets, net (excluding goodwill)5,2375,320
Prepaid expense4,634
Prepaid expense and other noncurrent assets1,050
Other undisclosed noncurrent assets(28,086)(28,690)
Total noncurrent assets:10,0546,548
Other undisclosed assets37,55437,559
TOTAL ASSETS:136,223115,759
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,8335,968
Accounts payable3,3044,018
Accrued liabilities214 
Taxes payable1,3151,951
Debt10,6414,444
Due to related parties1,362799
Other undisclosed current liabilities8,1315,995
Total current liabilities:24,96617,206
Noncurrent Liabilities
Liabilities, other than long-term debt8651,069
Deferred revenue and credits8021,063
Derivative instruments and hedges, liabilities626
Other undisclosed noncurrent liabilities 1,270
Total noncurrent liabilities:8652,338
Total liabilities:25,83019,544
Stockholders' equity
Stockholders' equity attributable to parent, including:110,39396,215
Common stock88
Additional paid in capital37,63137,021
Accumulated other comprehensive income11,8118,774
Retained earnings54,99044,515
Other undisclosed stockholders' equity attributable to parent5,9535,897
Total stockholders' equity:110,39396,215
TOTAL LIABILITIES AND EQUITY:136,223115,759

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
42,48433,587
Cost of revenue
(Cost of Goods and Services Sold)
(22,785)(16,898)
Other undisclosed gross profit1,7921,803
Gross profit:21,49118,492
Operating expenses(8,478)(9,941)
Operating income:13,0138,551
Nonoperating expense(81)(170)
Investment income, nonoperating(11)38
Other nonoperating income48499
Income from continuing operations before income taxes:12,9328,381
Income tax expense(2,401)(2,168)
Net income available to common stockholders, diluted:10,5306,212

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net income:10,5306,212
Comprehensive income:10,5306,212
Other undisclosed comprehensive income, net of tax, attributable to parent3,038663
Comprehensive income, net of tax, attributable to parent:13,5686,875

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: